5.96
price down icon4.79%   -0.30
after-market Handel nachbörslich: 5.93 -0.03 -0.50%
loading
Schlusskurs vom Vortag:
$6.26
Offen:
$6
24-Stunden-Volumen:
186.78K
Relative Volume:
0.73
Marktkapitalisierung:
$125.32M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-52.07M
KGV:
-28.70
EPS:
-0.2077
Netto-Cashflow:
$-44.93M
1W Leistung:
-15.10%
1M Leistung:
-18.36%
6M Leistung:
-32.58%
1J Leistung:
-66.13%
1-Tages-Spanne:
Value
$5.89
$6.20
1-Wochen-Bereich:
Value
$5.73
$7.0895
52-Wochen-Spanne:
Value
$5.73
$17.48

Cybin Inc Stock (CYBN) Company Profile

Name
Firmenname
Cybin Inc
Name
Telefon
908 764 8385
Name
Adresse
100 King Street West, Suite 5600, Toronto
Name
Mitarbeiter
38
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
CYBN's Discussions on Twitter

Vergleichen Sie CYBN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CYBN
Cybin Inc
5.96 125.32M 0 -52.07M -44.93M -0.2077
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 124.29B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 68.39B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 35.99B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.93B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.47B 3.81B -644.79M -669.77M -6.24

Cybin Inc Stock (CYBN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-13 Eingeleitet Guggenheim Buy
2021-11-19 Herabstufung Maxim Group Buy → Hold

Cybin Inc Aktie (CYBN) Neueste Nachrichten

pulisher
Mar 28, 2025

Cybin to Participate in Cowen’s Psychedelics & Novel Mechanisms in Neuropsychiatry Virtual Summit on July 13th - Business Wire

Mar 28, 2025
pulisher
Mar 16, 2025

(CYBN) Investment Analysis and Advice - news.stocktradersdaily.com

Mar 16, 2025
pulisher
Mar 13, 2025

Guggenheim Initiates Coverage of Cybin (CYBN) with Buy Recommendation - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Cybin wins new Buy from Guggenheim: potential to challenge J&J’s Spravato cited - Seeking Alpha

Mar 13, 2025
pulisher
Mar 12, 2025

Cybin initiated with a Buy at Guggenheim - TipRanks

Mar 12, 2025
pulisher
Mar 11, 2025

Cybin Inc. Reports Q3 2025 Financial Results and Strategic Progress - TipRanks

Mar 11, 2025
pulisher
Mar 07, 2025

Psychedelic Science 2025 Announces Select Speakers for the Leading Conference on Psychedelic Research, Policy, and Thought Leadership - GlobeNewswire Inc.

Mar 07, 2025
pulisher
Mar 04, 2025

Cybin Inc. (CYBN) Loses -25.81% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Nasdaq

Mar 04, 2025
pulisher
Mar 01, 2025

Cybin Inc. (CYBN): Among the Best Psychedelic Stocks to Buy in 2025 - Insider Monkey

Mar 01, 2025
pulisher
Feb 28, 2025

12 Best Psychedelic Stocks to Buy in 2025 - Insider Monkey

Feb 28, 2025
pulisher
Feb 23, 2025

Wall Street Analysts Think Cybin Inc. (CYBN) Could Surge 988.67%: Read This Before Placing a Bet - MSN

Feb 23, 2025
pulisher
Feb 23, 2025

Cybin (OTCMKTS:CLXPF) Shares Down 2.5%Here's What Happened - MarketBeat

Feb 23, 2025
pulisher
Feb 23, 2025

How to Take Advantage of moves in (CYBN) - news.stocktradersdaily.com

Feb 23, 2025
pulisher
Feb 20, 2025

Revolutionizing Mental Health Through Psychedelic Therapeutics | by Dr. Gleb Tsipursky | Feb, 2025 - DataDrivenInvestor

Feb 20, 2025
pulisher
Feb 18, 2025

Cybin (NYSE:CYBN) Price Target Cut to $150.00 by Analysts at HC Wainwright - MarketBeat

Feb 18, 2025
pulisher
Feb 16, 2025

Cybin (OTCMKTS:CYBN) Trading Up 1.2%Here's Why - MarketBeat

Feb 16, 2025
pulisher
Feb 16, 2025

Canaccord cuts Cybin stock target to $73, maintains Buy rating - MSN

Feb 16, 2025
pulisher
Feb 16, 2025

Cybin (NYSE:CYBN) Price Target Lowered to $73.00 at Canaccord Genuity Group - MarketBeat

Feb 16, 2025
pulisher
Feb 14, 2025

Cybin stock price target cut to $150 at H.C. Wainwright - MSN

Feb 14, 2025
pulisher
Feb 13, 2025

Cybin stock price target cut to $150 at H.C. Wainwright By Investing.com - Investing.com Australia

Feb 13, 2025
pulisher
Feb 12, 2025

Canaccord cuts Cybin stock target to $73, maintains Buy rating By Investing.com - Investing.com Nigeria

Feb 12, 2025
pulisher
Feb 12, 2025

(CYBN) Investment Analysis - Stock Traders Daily

Feb 12, 2025
pulisher
Feb 11, 2025

Cybin sees third-quarter loss on R&D costs, advances clinical programs - Green Market Report

Feb 11, 2025
pulisher
Feb 10, 2025

Cybin Accelerates PARADIGM Program for Depression Treatment - TipRanks

Feb 10, 2025
pulisher
Feb 10, 2025

Cybin's Depression Drug Shows Perfect Response Rate, Advances to Pivotal Phase 3 with C$136M War Chest - StockTitan

Feb 10, 2025
pulisher
Feb 10, 2025

Upstart (UPST) Reports Earnings Tomorrow: What To Expect - The Globe and Mail

Feb 10, 2025
pulisher
Feb 10, 2025

Cybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights - Business Wire

Feb 10, 2025
pulisher
Feb 07, 2025

Trade thoughts for Gold futures - The Globe and Mail

Feb 07, 2025
pulisher
Feb 07, 2025

Is Rigetti Computing a Millionaire-Maker Stock? - The Globe and Mail

Feb 07, 2025
pulisher
Feb 03, 2025

HC Wainwright Forecasts Cybin's Q3 Earnings (NYSE:CYBN) - MarketBeat

Feb 03, 2025
pulisher
Feb 03, 2025

What is HC Wainwright's Estimate for Cybin FY2029 Earnings? - MarketBeat

Feb 03, 2025
pulisher
Feb 02, 2025

Cybin (OTCMKTS:CLXPF) Shares Up 1.9%What's Next? - MarketBeat

Feb 02, 2025
pulisher
Feb 01, 2025

What is HC Wainwright's Forecast for Cybin FY2029 Earnings? - MarketBeat

Feb 01, 2025
pulisher
Jan 31, 2025

How To Trade (CYBN) - Stock Traders Daily

Jan 31, 2025
pulisher
Jan 31, 2025

HC Wainwright Issues Optimistic Estimate for Cybin Earnings - Defense World

Jan 31, 2025

Finanzdaten der Cybin Inc-Aktie (CYBN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Kapitalisierung:     |  Volumen (24h):